Whole genome sequencing on DNA
Ended Purchase Order Awarded
- Contract number
- 75N92022P00150
- Awardee
-
Psomagen Inc. UEI ZBGTCAAMFL93 Part of Macrogen, Inc.
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $484,000
Award facts
- Contract value 100% obligated
- $484,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart Lung and Blood Institute awarded a $484,000 purchase order to Psomagen Inc. for whole genome sequencing on DNA, issued May 17, 2022, with completion by May 16, 2023. Work is performed in Rockville, Maryland. Psomagen, a foreign-owned subsidiary of South Korea-based Macrogen Inc., operates CLIA-certified and CAP-accredited laboratory facilities and delivers whole genome sequencing, RNA sequencing, single-cell genomics, and bioinformatics analysis across precision medicine and cardiovascular research initiatives.
Quick answers
Who was awarded contract 75N92022P00150?
75N92022P00150 was awarded to Psomagen Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on May 17, 2022.
How much is contract 75N92022P00150 worth?
The government has obligated $484,000 on 75N92022P00150.
Was contract 75N92022P00150 competed?
The extent of competition for 75N92022P00150 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award